Evaluation of Icotinib in Metastatic Triple-negative Breast Cancer After Second-line Therapy
Clinical trial NCT02362230 · TERMINATED
Trial details
- NCT number
- NCT02362230
- Sponsor
- Sun Yat-sen University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2020-12-15
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.